Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor
ConclusionsYangonin protects against NAFLD due to its activation of FXR signalling to inhibit hepatic lipogenesis and gluconeogenesis, and to promote lipid metabolism and glycogen synthesis, as well as insulin sensitivity.Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
More News: Alcoholism | Cholesterol | Diets | Drugs & Pharmacology | Fatty Liver Disease (FLD) | Genetics | High Fat | Insulin | Kava | Liver | Liver Disease | Men | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Study | Urology & Nephrology